The Use of Clonidine Hydrochloride in Ambulatory Hypertensive Patients

Abstract

Get full access to this article

View all access options for this article.

References

Stahle, H. et al.: zum D.B.P. angemeldet (1962)

Duncan, D.B. : Multiple Range and Multiple F. Tests. Biometrics 11: 1, 1955

Hoefke, W. , Kobinger, W. : Pharmacologic effects of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride, a new antihypertensive substance, Arzneimittel-Forsch. 16: 1038, Aug. 1966

Graubner, W. , Wolf, M. : Critical reflections about the mechanism of action of 2-(2,6-dichlorophenyl-amino)-2-imidazoline hydrochloride, Arzneimittel-Forsch. 16: 1055, Aug. 1966

Schmitt, H. and Schmitt, H. : Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155, Catapresan). European J. Pharm., Amsterdam, 6: 8-12, 1969

Kobinger, W. and Walland, A. : Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hcl. European J. Pharm., Amsterdam, 2: 155-162, 1967

Scriabine, A. et al: Cardiac slowing effects of Clonidine (ST-155) in dogs. J. Pharm. & Exper. Ther. 171: 256-263, 1970

Simpson, G. ; Kunz-Bartholini, E. ; and Watts, T. : A preliminary evaluation of the sedative effects of Catapres, a new antihypertensive agent, in chronic schizophrenic patients, J. Clinic. Pharmacol. , 2: 221-225, 1967

von Albert, H. : Documentation of the sedative effect of Capapres by electronystagmography . Symposium on Catapres, Ulm . Editors Heilmeyer, L. et al, G. Thieme, Stuttgart, 176-179, 1968

10.

Senft, G. et al.: Inhibition of insulin secretion by stimulating substances of a-receptors, Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 260: 309, 1968

11.

Robson, R. and Kaplan, H. : An involvement of St 155 [2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, Catapres] in cholinergic mechanisms. European J. Pharm., Amsterdam, 5: 328-337, 1969

12.

Robson, R. ; Kaplan, H. ; and Laforce, S. : An investigation into the bradycardic effects of ST 155 [2-(2,6-dichlorophenylamino)-2-imidazoline hcl.] in the anesthetized dog. J. Pharm. & Exper. Ther. 169: 120-131. 1969

13.

Stötzer, H. et al: Retinal degeneration in the rat. Its dependency from intensity of illumination and content of vitamin A in the food. Arzneimittel-Forschung 20: 811-817, 1970

14.

Rehbinder, D. and Deckers, W. : Pharmacokinetic and metabolic studies of 2-(2,6-dischlorophenylamino)-2-imidazoline hydrochloride (St 155)) Arzneimittel-Forschung, 19: 169-176, 1969

15.

Kobinger, W. and Hoefke, W. : Pharmacological investigations on the site and mode of action of new antihypertensive agent. Symposium on Catapres, Ulm. Editors Heilmeyer, L. et al ; G. Thieme, Stuttgart, 4-17, 1968